Register for our free email digests:
Eli Lilly & Co.
www.lilly.com
Latest From Eli Lilly & Co.
Colorectal, Bladder Cancer Therapies Are Top Prospects For April US FDA Approvals
Sanofi’s next-generation meningococcal vaccine, broader use of Bristol-Myers Squibb’s Reblozyl move toward approval; United Therapeutics foreshadows Trevyent regulatory difficulties.
Coronavirus Update: Drug Shortages On Horizon, Firms Offer Medical Staff For The Fight, More Studies Start
Fears over shortages of drugs needed for ventilated patients rise, while Merck & Co, Pfizer and Lilly allow their medics to volunteer, and attention turns to beta-interferon products and NK cell therapies to fight the virus.
Neurology At The Forefront Of US FDA Complex Innovative Trial Design Pilot
Wave’s Duchenne muscular dystrophy drug and Lilly’s chronic pain R&D will test the agency’s CID meeting pilot program, while FDA issues draft guidance that highlights potential uses for complex innovative trial designs.
US FDA And Sponsors Resolve Disclosure Issues On Complex Trial Design Pilot Projects
Agency officials can now discuss the ideas that have been accepted, though not in great detail.
Company Information
- Industry
- Pharmaceuticals
- Therapeutic Areas
- Cancer
- Cardiovascular
- Infectious & Viral Diseases
- Metabolic Disorders
- Neurology, Nervous System
- Alias(es)
- Ownership
- Public
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Company Type
- Big Pharma
- Parent & Subsidiaries
-
Eli Lilly & Co.
- Alnara Pharmaceuticals Inc.
- Applied Molecular Evolution Inc.
- Armo BioSciences Inc.
- AurKa Pharma Inc.
- Avid Radiopharmaceuticals Inc.
- Chorus
- Chugai Lilly Clinical Research Co. Ltd.
- CoLucid Pharmaceuticals Inc.
- Dermira Inc.
- Eli Lilly & Co. (India) Pvt. Ltd.
- Eli Lilly Canada Inc.
- Eli Lilly Deutschland GMBH
- Eli Lilly Japan
- Eli Lilly Ranbaxy Ltd.
- Eli Lilly Suzhou Pharmaceutical Group Co. Ltd.
- Hypnion Inc.
- Icos Corp.
- ImClone Systems Inc.
- InnoCentive LLC
- Lilly Research Centre Ltd.
- Lilly Research Laboratories
- Loxo Oncology Inc.
- Medical Devices & Diagnostics
- Pacific Biotech Inc.
- SGX Pharmaceuticals Inc.
- Senior Management
-
David Ricks, CEO
Joshua L Smiley, SVP, CFO
Daniel M Skovronsky, MD, PhD, SVP, CSO - Contact Info
-
Eli Lilly & Co.
Phone: (317) 276-2000
Lilly Corporate Ctr.
Indianapolis, IN 46285
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice